XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 03, 2024
May 31, 2024
Jan. 02, 2024
Jun. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
May 31, 2022
Subsidiary, Sale of Stock [Line Items]                
Preferred stock, shares authorized       10,000,000 10,000,000   10,000,000  
Preferred stock, shares issued       0 0   0  
Preferred stock, shares outstanding       0 0   0  
Common stock, shares authorized       100,000,000 100,000,000   100,000,000  
Common stock, shares issued       5,939,516 5,939,516   4,617,798  
Common stock, shares outstanding       5,939,516 5,939,516   4,617,798  
Fair value of common stock $ 214,949              
Share price $ 2.66              
Stock-based compensation       $ 7,884 $ 15,500 $ 338,021    
Unrecognized compensation cost related       $ 0 $ 0      
Weighted average remaining contractual life of outstanding warrants       4 years 11 months 4 days 4 years 11 months 4 days      
Total intrinsic value       $ 0 $ 0      
Share-Based Payment Arrangement, Option [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of shares, granted     5,590   5,590      
Exercise price, per share     $ 5.50   $ 5.50      
Estimated fair market value of option     $ 15,500          
Weighted average remaining contract life in years         7 years 1 month 20 days      
Stock options intrinsic value exercised         $ 0      
Stock Options And Warrats [Member]                
Subsidiary, Sale of Stock [Line Items]                
Potential common share equivalents         2,727,125      
Common Stock [Member]                
Subsidiary, Sale of Stock [Line Items]                
Issuance of warrants       1,240,910        
Underwriting Agreement [Member] | Common Stock [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price               $ 6.33
Exercise term   5 years            
Exercise price of warrant   6.33            
Underwriting Agreement [Member] | Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Issuance of warrant   $ 83,639            
Underwriting Agreement [Member] | Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Public offering price   186,136            
Underwriting Agreement [Member] | Non-Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Public offering price   186,136            
Promissory Note Agreements [Member]                
Subsidiary, Sale of Stock [Line Items]                
Debt instrument interest rate stated percentage 10.00%              
IPO [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price $ 6.33              
Exercise term 5 years              
Issuance of warrants 1,240,910              
Gross proceeds $ 6,800,000              
Net proceeds $ 5,900,000              
Share price $ 5.50              
Issuance of restricted common stock 80,808              
Number of warrants 1,240,910              
Exercise term 5 years              
IPO [Member] | Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price $ 6.33              
Issuance of warrants 76,538              
Exercise term 5 years              
IPO [Member] | Non-Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price $ 6.33              
Exercise term 5 years              
IPO [Member] | Underwriting Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Aggregate sale of initial public offering   1,240,910            
Public price   $ 5.50            
Exercise price $ 6.33              
Exercise term 5 years              
Number of warrants 83,639              
IPO [Member] | Underwriting Agreement [Member] | Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of warrants 76,538              
IPO [Member] | Underwriting Agreement [Member] | Non-Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of warrants 76,538              
IPO [Member] | Promissory Note Agreements [Member]                
Subsidiary, Sale of Stock [Line Items]                
Debt instrument interest rate stated percentage 10.00%              
Share price $ 5.50              
Issuance of restricted common stock 808.08              
Accrued interest $ 463,534              
One Tradeable Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price   $ 6.33            
Exercise term   5 years            
Underwriting Agreement [Member] | Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price   $ 6.33            
Exercise term   5 years            
Over-Allotment Option [Member] | Non-Tradeable Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Issuance of warrants 76,538